Glenmark Pharmaceuticals has informed that it has attached media release on 1st December 2020 titled ‘Glenmark Pharmaceuticals receives ANDA tentative approval for Axitinib Tablets, 1 mg and 5 mg’ which is self explanatory.
The above information is a part of company’s filings submitted to BSE.